Glenmark Pharma Arm Gets Final Nod for Rizatriptan Benzoate

Glenmark Pharmaceuticals said its US subsidiary Glenmark Generics had obtained final approval for rizatriptan benzoate tablets in the strengths of 5 mg and 10 mg, its generic version of Merck’s Maxalt tablets.
RTT News